由于有研究显示类似的血管堵塞是导致新冠重症患者死亡的主要原因之一，研究人员希望这种药物在将来可以用于此类重症患者的治疗。
Studies indicate that such blood vessel blockage is a leading cause of death in severe COVID-19 cases, so the researchers hope this drug can be use to treat such severe cases in the future.